Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1 10Phase 1/2 5Phase NA 2Phase 2/3 2Phase 4 1Phase 3 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Stomatitis 1Pain 1Mucositis 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Cisplatin 22Fluorouracil 21Radiotherapy 18Gemcitabine 17Docetaxel 16Oxaliplatin 15Paclitaxel 14Carboplatin 13Capecitabine 13Bevacizumab 13Leucovorin 11Cyclophosphamide 11Irinotecan 10Drug Therapy 10Cytarabine 9Saline Solution 7Magnetic Resonance Spectroscopy 7Letrozole 7Dexamethasone 7Rituximab 6Nivolumab 6Methotrexate 6Exercise 6Etoposide 6Electroporation 6Doxorubicin 6pembrolizumab 5Pemetrexed 5Metformin 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × Diphenhydramine × Clear all
NCT04862585 2025-08-20

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

Ohio State University Comprehensive Cancer Center

Phase 2/3 Completed
130 enrolled 8 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms

NCT01837446 2013-04-23

Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer

Isfahan University of Medical Sciences

Phase 2/3 Completed
30 enrolled
Other

Pain, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡